Delayed onset autoimmune cholangitis in a patient treated with pembrolizumab

被引：0

作者：

Newington, Joshua ^{[1
]}

Patterson, Daniel ^{[2
]}

Sanchez, Pilar ^{[3
]}

机构：

[1] Univ Cambridge, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0SP, England

[2] West Suffolk Hosp, Dept Oncol, Bury St Edmunds IP33 2QZ, England

[3] West Suffolk Hosp, Dept Radiol, Bury St Edmunds IP33 2QZ, England

来源：

BJR CASE REPORTS | 2024年 / 10卷 / 06期

关键词：

pembrolizumab; autoimmune cholangitis; delayed onset;

D O I：

10.1093/bjrcr/uaae040

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

This case study describes a female patient in her late 70s who developed autoimmune cholangitis a year after finishing 35 cycles of pembrolizumab for the treatment of her non-small cell lung cancer. The diagnosis was initially missed and delayed; the patient's agoraphobia and the COVID-19 pandemic were noted as contributing factors.

引用

页数：4

共 50 条

[41] Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report
Yu, Xiao-He
Huang, Jian
Ge, Nai-Jian
Yang, Ye-Fa
Zhao, Jin-Yan
WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (10) : 2281 - 2288
[42] Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib
Airo, Giulia
Maffezzoli, Michele
Lazzarin, Alessandro
Bianconcini, Michele
Greco, Alessandro
Buti, Sebastiano
Leonetti, Alessandro
IMMUNOTHERAPY, 2022, 14 (16) : 1297 - 1305
[43] Pembrolizumab-Induced Autoimmune Grade 4 Neutropenia in a Patient With Advanced Bladder Cancer: A Case Report
Baleiras, Mafalda Miranda
Vasques, Carolina
Pinto, Marta
Miranda, Helena
Martins, Ana
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
[44] Coeliac disease and autoimmune cholangitis: a case report
Marignani, M
Angeletti, S
Mari, T
D'Alessandro, P
Palumb, P
Dato, A
Zullo, A
DIGESTIVE AND LIVER DISEASE, 2002, 34 (12) : 862 - 865
[45] The pathology of primary biliary cirrhosis and autoimmune cholangitis
Ludwig, J
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (04) : 601 - 613
[46] Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumab
El Rassy, Elie
Assi, Tarek
Rizkallah, Jamale
Kattan, Joseph
IMMUNOTHERAPY, 2017, 9 (04) : 309 - 311
[47] A pathological complete response and adrenal insufficiency in a patient with advanced renal pelvic cancer treated with pembrolizumab
Suzuki, Kotaro
Murata, Kazuki
Wakita, Naoto
Terakawa, Tomoaki
Nakanishi, Takaaki
Hara, Takuto
Hyodo, Yoji
Chiba, Koji
Teishima, Jun
Nakano, Yuzo
Miyake, Hideaki
INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 391 - 394
[48] Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy
Liang, Ian
Chu, Geoffrey
Zielinski, Robert
CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 188 - 193
[49] Positive rechallenge of hemophagocytic lymphohistio- cytosis in a patient treated with isoniazide, pembrolizumab, carboplatine and pemetrexed
Bertin, Blandine
Auffret, Marine
Chabert, Paul
THERAPIE, 2023, 78 (06): : 762 - 764
[50] Sebaceous carcinoma of the eyelid in a patient with Muir-Torre syndrome treated with pembrolizumab: A case report
Abdalla, Ahmed
Souza, Gabriel Roman
Mahadevan, Daruka
CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2022, 6

← 1 2 3 4 5 →